Effect of specific immunotherapy in eosinophil cationic protein release after specific nasal provocation

Clinical and Applied Immunology Reviews

Volumn 1, Issue 3-4, 2001, Pages 243-248

  Branco Ferreira, M ^a   Silva, S ^a   Pereira dos Santos, M C ^a   Palma Carlos, M L ^a   Palma Carlos, A G ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Allergic rhinitis; Nasal ECP; Nasal provocation; Specific immunotheraphy

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; POLLEN ANTIGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NOSE MUCUS; NOSE PROVOCATION TEST; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0042568328     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(01)00014-9     Document Type: Article

References (26)

1. R.M. Naclerio F.M. Baroody A. Kagey-Sobotka L.M. Lichtenstein Basophils and eosinophils in allergic rhinitis J Allergy Clin Immunol 94 1994 1303-1309
2. G. Di-Lorenzo P. Mansueto M. Melluso G. Candore A. Colombo M.E. Pellitteri A. Drago M. Potestio C. Caruso Allergic rhinitis to grass pollen measurement of inflammatory mediators of mast cells and eosinophils in native nasal fluid lavage and in serum out of and during the pollen season J Allergy Clin Immunol 100 1997 832-837
3. D. Wang P. Clement J. Smitz M. de-Waele M.P. Derde Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions Allergy 50 1995 147-151
4. S.J. Wilson Lau L, Howart P H. Inflammatory mediators in naturally occuring rhinitis Clin Exp Allergy 28 1997 220-227
5. L. Hakansson C. Heinrich S. Rak P. Venge Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season effect of immunotherapy J Allergy Clin Immunol 99 1997 551-562
6. W.A. Nish E.N. Charlesworth T.L. Davis B.A. Whisman S. Valtier M.G. Charlesworth K.M. Leiferman The effect of immunotherapy on the cutaneous late phase response to antigen J Allergy Clin Immunol 93 1994 484-493
7. S. Echechipía A.I. Tabar T. Lobera D. Munoz A. Rodriguez A. Blasco J.M. Olaguibel M. Casanovas Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehide-modified extract against an unmodified extract a comparative study of efficacy, tollerance and in vivo and in vitro modification of parameters J Invest Allergol Clin Immunol 5 1995 325-332
8. G.M. Halpern Critical evaluation of the clinical relevance of the IgG subclasses assays Allerg Immunol Paris 25 1993 10-18
9. T. Platts-Mills R.K. von Maur K. Ishizaka P.S. Norman L.M. Lichtenstein IgA anti IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release J Clin Invest 57 1976 1041-1051
10. H. Otsuka A. Mezawa M. Ohnishi K. Okubo H. Seki M. Okuda Changes in nasal metachromatic cells during allergen immunotherapy Clin Exp Allergy 21 1991 115-120
11. M. Nagata M. Shibasaki Y. Sakamoto T. Fukuda S. Makino K. Yamamoto Y. Dohi Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotatic activity from mononuclear cells in patients with atopis asthma J Allergy Clin Immunol 94 1994 160-166
12. L.M. Lichtenstein P.S. Norman W.L. Winkerwerder A single-year immunotherapy for ragweed hay fever Ann Intern Med 75 1971 663-667
13. S. McHugh J. Deighton I. Rifkin P. Evan Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture Eur J Immunol 26 1996 1260-1265
14. P. Kuna R. Alam B. Kuzminska J. Rozniecki Effects of Immunotherapy on the production of histamine releasing factor[s] by mononuclear cells from asthmatic patients J Allergy Clin Immunol 81 1988 494
15. L. Klimek H. Wolf T. Mewes D. Dormann A. Reske-Kunz J. Schnitker W. Mann The effect of short term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions J Allergy Clin Immunol 103 1999 47-53
16. G. Passalacqua M. Albano S. Ruffoni C. Pronzato A.M. Riccio L. Di-Berardino A. Scordamaglia G.W. Canonica Nasal Immunotherapy to Parietária evidence of reduction of local inflammation Am J Respir Crit Care 152 1995 461-466
17. G. D'Amato G. Liccardi M. Russo M. Saggese M. D'Amato Measurement of serum levels of eosiniphil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietária pollen treated and untreated with specific immunotherapy Allergy 51 1996 245-250
18. Y. Ohashi Y. Nakai Y. Kakinoki Y. Ohno H. Sakamoto A. Kato A. Tanaka Effect of immunotherapy on serum levels of eosinophilic cationic protein in perennial allergic rhinitis Ann Otol Rhinol Laryngol 106 1997 848-853
19. Y. Ohashi Y. Nakai Y. Kakinoki Y. Ohno H. Okamoto H. Sakamoto A. Kato A. Tanaka The effect of immunotherapy on the serum levels of eosinophil cationic protein in seasonal allergic rhinitis Clin Otolaryngol 22 1997 100-105
20. E. Fanales-Belasio A. Ciofalo G. Zambetti I.J. Ansotegui E. Scala R. Paganelli F. Filiaci Intranasal immunotherapy with Dermatophagoides extract in vivo and in vitro results of a double-blind placebo-controlled trial Rhinology 33 1995 126-131
21. B.R. Balda H. Wolf C. Baumgarten L. Klimek G. Rasp G. Kunkel S. Muller W. Mann B. Hauswald W. Heppt B. Przybilla U. Amon R. Bischoff G. Becher S. Hummel P.J. Frosch T. Rustemeyer L. Jager R. Brehler T. Luger J. Schnitker Tree pollen allergy is efficiently treated by short term immunotherapy [STI] with seven preseasonal injections of molecular standardized allergens Allergy 53 1998 740-748
22. D. Vourdas E. Syrigou P. Potamianou F. Carat T. Batard C. Andre P.S. Papageorgiou Double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjuntivitis and mild asthma due to olive pollen sensitization Allergy 53 1998 662-672
23. D. Marciniak J. Tomaszewicz-Fryca T. Plusa A. Chcialowski Eosinophil cationic protein in children with allergic diseases of the respiratory tract in exacerbation and remission of symptoms Pol Merkuriusz Lek 4 1998 75-77
24. G. Passalacqua M. Albano L. Fregonese A. Riccio C. Pronzato G.S. Mela G.W. Canonica Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjuntivite Lancet 351 1998 629-632
25. S. Rak L. Hakanson P. Venge Immunotherapy abrogates the generation of eosinophil and neutrophil chemotatic activity during pollen season J Allergy Clin Immunol 86 1990 706-713
26. S.P. Creticos D.G. Marsh D. Proud A. Kagey-Sobotka N.F. Adkinson L. Friedhoff R.M. Naclerio L.M. Lichtenstein P.S. Norman Responses to ragweed-pollen nasal challenge before and after immunotherapy J Allergy Clin Immunol 84 1989 197-205